Merck (NYSE: MRK) reported third-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q3 revenue of $13.2 billion, up 20% year-over-year and higher than the Wall Street projection. Net income of $1.75 per share was also well above the target that analysts had anticipated.
MRK shares rose 1% immediately following the announcement. The stock has gained a modest 5% since the beginning of this year.
Prior performance
Most Popular
QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view
Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter
Key takeaways from Amazon’s Q1 2024 earnings report
Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased
